Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants - A phase 3b, randomized controlled trial.mp4 (19.88 MB)
Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants - A phase 3b, randomized controlled trial
media
posted on 2019-10-07, 15:04 authored by Daniela ToneattoDaniela Toneatto, Mercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi BhusalMercedes Macias Parra, Angela Gentile, Jorge Alejandro Vazquez Narvaez, Alejandro Capdevila, Angel Minguez, Monica Carrascal, Arnold Willemsen, Chiranjiwi Bhusal, Daniela Toneatto. Immunogenicity and safety of the 4CMenB and MenACWY-CRM meningococcal vaccines administered concomitantly in infants: A phase 3b, randomized controlled trial. Vaccine. 2018;36(50):7609-7617.
History
Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC